BEST OF FROM THE EDITOR
1.
ChatGPT Wrote This Editorial
2.
Ex-Pfizer Pro Tired Of The Word “Strategic”
3.
Who’s Afraid Of Their CDMO Getting Acquired?
4.
How A CDMO Should Communicate A Form 483
5.
When Batches At The CDMO Go Kaput
BEST OF GUEST COLUMNS
Essential Elements Of Technology Transfer
By Peter Alexander and Phillip Ramsey
EMA's Revised GMP Annex 1 Addresses Common Global Challenges For Sterile Products
By Peter H. Calcott, Ph.D., Calcott Consulting LLC
Biotech’s Market Outlook In 2023 And Beyond
By Steve Kemler, RSM US LLP
An Overview Of The 9 FDA Special Designations For Pipeline Drugs
By Ryan Chandanais, Two Labs
Trends In FDA FY2022 Inspection-Based Warning Letters
By Liz Oestreich, Madeleine Giaquinto, and Kalah Auchincloss
BEST OF INDUSTRY INSIGHTS
Three Trends To Know Before Selecting Your CDMO
By August Bioservices
Biopharma 4.0: Digital Transformation In The Biopharma Industry
By Chris Demers, Ph.D., Catalent Biologics
Key Trends Shaping The CDMO Industry In 2024 And Beyond
By Cory Lewis, INCOG BioPharma Services
Technology Transfers: A Beginner's Guide
By Lei Zheng, Pfizer CentreOne
State-Of-The-Art Bispecific Antibody Development
By Séverine Fagète, Leslie S. Wolfe, Niket Bubna, and Sigma S. Mostafa, KBI Biopharma
6.
Align CMC Strategy With Clinical Path Requirements And Timelines
By Lee Allen and Megan Mason, Lonza
7.
Accelerating Process Validation During Site-To-Site Technology Transfers
By Bora Pharmaceuticals
8.
Manufacturing Process Transfer: Challenges And Keys To Success
By AGC Biologics
9.
A Molecule’s Journey: Achieve Commercial Manufacturing Success
By Christian Cattaruzza, Steven Strubbe, Laure Valognes, et al., MilliporeSigma
10.
A Five-Point Strategy For Building A CMC Dossier
By Daniela Decina and Michele Duggan, Thermo Fisher Scientific
BEST OF SOLUTIONS
Early Development: Accelerating Molecules Through To Proof-Of-Concept
Quotient Sciences
State-Of-The-Art Aseptic Filling System
Emergent CDMO
Drug Product Manufacturing: Aseptic Fill/Finish
Ajinomoto Bio-Pharma Services
Biotransformation: Development, Application, And Scale-Up Of Enzymes
Asymchem
Adeno-Associated Virus (AAV) Biosafety Testing And Characterization Services
MilliporeSigma
Remaking How Medicines Are Made
Resilience US, Inc.
Large Molecule Biologics Made With Intelligent Collaboration
Pfizer CentreOne
Mississauga's Leadership In Environment, Health, And Safety
Bora Pharmaceuticals
Better Solutions For Your Drug Product
INCOG BioPharma Services
Sterile Formulation And Fill/Finish For Early-Phase Clinical Trials
Ascendia Pharma
